First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
Neutral
0.0
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
